SCHEMBL2835198

SCHEMBL2835198

Cc1cc2c(o1)CN(C)CC2Oc1ccc(Cl)c(Cl)c1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 6/20 0.37
SLC6A2 P23975 5/20 0.37
SLC6A3 Q01959 5/20 0.37
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
FPR2 P25090 2/20 0.34
PROKR1 Q8TCW9 2/20 0.34
KDM4E B2RXH2 3/20 0.33
OPRK1 P41145 2/20 0.32
HRH3 Q9Y5N1 1/20 0.32
ALDH1A1 P00352 2/20 0.32
PTGS2 P35354 1/20 0.31
USP2 O75604 1/20 0.31
USP1 O94782 1/20 0.31
USP8 P40818 1/20 0.31
OTUB1 Q96FW1 1/20 0.31
CYP2D6 P10635 3/20 0.30
KCNH2 Q12809 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2839559 0.99 SLC6A4 (0.36) SLC6A4SLC6A2SLC6A3MEN1KMT2A
Hydrochloric Acid SCHEMBL3579144 0.89 MCHR1 (0.33)
SCHEMBL2840872 0.88 OPRK1 (0.39) SLC6A4SLC6A2SLC6A3MEN1KMT2A
Hydrochloric Acid SCHEMBL2839503 0.87 OPRK1 (0.36) SLC6A4SLC6A2SLC6A3FPR2PROKR1
Hydrochloric Acid SCHEMBL2841081 0.87 L3MBTL1 (0.36) SLC6A4KMT2AKDM4EOPRK1ALDH1A1
Hydrochloric Acid SCHEMBL2836932 0.86 SLC6A4 (0.36) SLC6A4SLC6A2SLC6A3HRH3
Hydrochloric Acid SCHEMBL2835864 0.84 KMT2A (0.32) KMT2AHRH3ALDH1A1
Hydrochloric Acid SCHEMBL3584702 0.84 ALDH1A1 (0.31) OPRK1ALDH1A1
Hydrochloric Acid SCHEMBL3580232 0.82 SLC6A2 (0.31) SLC6A4SLC6A2SLC6A3
Hydrochloric Acid SCHEMBL2841523 0.82 SLC6A2 (0.38) SLC6A4SLC6A2SLC6A3FPR2PROKR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100048537-A1 HETEROARYL DERIVATIVES NIPPON SHINYAKU CO., LTD. (JP) 2010-02-25 US claimed
EP-2141168-A1 HETEROARYL DERIVATIVES Nippon Shinyaku Co., Ltd. (JP) 2010-01-06 EP claimed
US-8217031-B2 Heteroaryl derivatives NIPPON SHINYAKU CO., LTD. (JP) 2012-07-10 US disclosed
US-20100048537-A1 HETEROARYL DERIVATIVES NIPPON SHINYAKU CO., LTD. (JP) 2010-02-25 US disclosed
EP-2141168-A1 HETEROARYL DERIVATIVES Nippon Shinyaku Co., Ltd. (JP) 2010-01-06 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100048537-A1 HETEROARYL DERIVATIVES OPRD1, OPRM1, OPRK1 SLC6A4 185/4885SLC6A2 196/4885SLC6A3 118/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.